# clm_CCC1584CC243

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: 699,800,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-05-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_87BE0FC8B08C  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly net income: 699,800,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_CCC1584CC243, https://asof.is/claim/clm_CCC1584CC243, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/0000875320-23-000012-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532023000012/0000875320-23-000012-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-05-02)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_net_income | 930,500,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_CCC1584CC243](/claim/clm_CCC1584CC243.md) | [clm_4BC06D9A5911](/claim/clm_4BC06D9A5911.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.